These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of treatment with anti-IL-2-receptor monoclonal antibody and CsA on peripheral nerve allograft rejection. Grochowicz PM; Romaniuk A; Diamantstein T; Olszewski WL Transplant Proc; 1987 Oct; 19(5):4302-3. PubMed ID: 3118540 [No Abstract] [Full Text] [Related]
8. Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation. Padberg WM; Di Stefano R; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL; Kupiec-Weglinski JW Transplant Proc; 1987 Oct; 19(5):4234-5. PubMed ID: 3118539 [No Abstract] [Full Text] [Related]
9. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. Harrison PC; Mainolfi E; Madwed JB J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853 [TBL] [Abstract][Full Text] [Related]
11. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections. Diamantstein T Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248 [No Abstract] [Full Text] [Related]
12. The lymphocyte subpopulations in cyclosporine-treated human heart rejection. Weintraub D; Masek M; Billingham ME J Heart Transplant; 1985 Feb; 4(2):213-6. PubMed ID: 3916488 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of cyclosporine in preventing cardiac allograft rejection. I. Rate of entry of lymphocytes from the blood, fibrin deposition, and expression of Ia antigens on infiltrating cells. Cox JH; Chisholm PM Transplantation; 1987 Mar; 43(3):338-42. PubMed ID: 3547786 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival. Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026 [TBL] [Abstract][Full Text] [Related]
15. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059 [No Abstract] [Full Text] [Related]
16. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts. Dallman MJ; Wood KJ; Morris PJ Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832 [No Abstract] [Full Text] [Related]
18. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production. Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913 [No Abstract] [Full Text] [Related]
19. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633 [No Abstract] [Full Text] [Related]
20. Immunological study of cyclosporine in heterotopic transplantation of canine hearts. Suzuki S; Mizuochi I; Amemiya H Transplantation; 1985 May; 39(5):565-8. PubMed ID: 3158109 [No Abstract] [Full Text] [Related] [Next] [New Search]